Charles Kummeth
2018
In 2018, Charles Kummeth earned a total compensation of $9.7M as President and CEO at Bio-Techne, a 6% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,610,925 |
|---|---|
| Option Awards | $3,550,081 |
| Salary | $911,000 |
| Stock Awards | $3,550,008 |
| Other | $42,860 |
| Total | $9,664,874 |
Kummeth received $3.6M in option awards, accounting for 37% of the total pay in 2018.
Kummeth also received $1.6M in non-equity incentive plan, $911K in salary, $3.6M in stock awards and $42.9K in other compensation.
Rankings
In 2018, Charles Kummeth's compensation ranked 734th out of 14,244 executives tracked by ExecPay. In other words, Kummeth earned more than 94.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 734 out of 14,244 | 95th |
Division Manufacturing | 240 out of 5,765 | 96th |
Major group Chemicals And Allied Products | 69 out of 2,128 | 97th |
Industry group Drugs | 53 out of 1,817 | 97th |
Industry Biological Products, Except Diagnostic Substances | 15 out of 339 | 96th |
Source: SEC filing on September 9, 2019.
Kummeth's colleagues
We found four more compensation records of executives who worked with Charles Kummeth at Bio-Techne in 2018.